(Q63339258)
Statements
A Phase 2, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of IPI-926 in Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma (English)
0 references
February 2011
0 references
November 2013
0 references
105
0 references
18 year
0 references